368 related articles for article (PubMed ID: 22852863)
1. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
[TBL] [Abstract][Full Text] [Related]
2. Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma.
Klimowicz AC; Bose P; Nakoneshny SC; Dean M; Huang L; Chandarana S; Magliocco AM; Wayne Matthews T; Brockton NT; Dort JC
Eur J Cancer; 2012 Sep; 48(14):2166-74. PubMed ID: 22892062
[TBL] [Abstract][Full Text] [Related]
3. Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma.
Coutinho-Camillo CM; Lourenço SV; Nishimoto IN; Kowalski LP; Soares FA
Histopathology; 2010 Aug; 57(2):304-16. PubMed ID: 20716171
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
Zhang M; Zhang P; Zhang C; Sun J; Wang L; Li J; Tian Z; Chen W
J Oral Pathol Med; 2009 Mar; 38(3):307-13. PubMed ID: 18710422
[TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma.
Klimowicz AC; Bose P; Petrillo SK; Magliocco AM; Dort JC; Brockton NT
Br J Cancer; 2013 Oct; 109(7):1859-66. PubMed ID: 24008660
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
[TBL] [Abstract][Full Text] [Related]
7. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma.
Camisasca DR; Honorato J; Bernardo V; da Silva LE; da Fonseca EC; de Faria PA; Dias FL; Lourenço Sde Q
Oral Oncol; 2009 Mar; 45(3):225-33. PubMed ID: 18715811
[TBL] [Abstract][Full Text] [Related]
8. Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells.
Palve VC; Teni TR
Radiat Oncol; 2012 Aug; 7():135. PubMed ID: 22873792
[TBL] [Abstract][Full Text] [Related]
9. Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.
Loro LL; Johannessen AC; Vintermyr OK
J Clin Pathol; 2005 Nov; 58(11):1157-62. PubMed ID: 16254104
[TBL] [Abstract][Full Text] [Related]
10. Bcl-xL protein: predictor of complete tumor response in patients with oral cancer treated with curative radiotherapy.
Mallick S; Agarwal J; Kannan S; Pawar S; Kane S; Teni T
Head Neck; 2013 Oct; 35(10):1448-53. PubMed ID: 22987535
[TBL] [Abstract][Full Text] [Related]
11. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
[TBL] [Abstract][Full Text] [Related]
12. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
[TBL] [Abstract][Full Text] [Related]
13. Expression profile of apoptotic mediators and proliferative markers in oral squamous cell carcinoma.
Ahmed MM
J Egypt Natl Canc Inst; 2009 Jun; 21(2):85-92. PubMed ID: 21057559
[TBL] [Abstract][Full Text] [Related]
14. Fractal analysis of nuclear histology integrates tumor and stromal features into a single prognostic factor of the oral cancer microenvironment.
Bose P; Brockton NT; Guggisberg K; Nakoneshny SC; Kornaga E; Klimowicz AC; Tambasco M; Dort JC
BMC Cancer; 2015 May; 15():409. PubMed ID: 25976920
[TBL] [Abstract][Full Text] [Related]
15. Bcl-XL protein levels determine apoptotic index in pancreatic carcinoma.
Sharma J; Srinivasan R; Majumdar S; Mir S; Radotra BD; Wig JD
Pancreas; 2005 May; 30(4):337-42. PubMed ID: 15841044
[TBL] [Abstract][Full Text] [Related]
16. Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma.
Barber BR; Biron VL; Klimowicz AC; Puttagunta L; Côté DW; Seikaly H
J Otolaryngol Head Neck Surg; 2013 Oct; 42(1):53. PubMed ID: 24401183
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
18. Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis.
Loro LL; Vintermyr OK; Liavaag PG; Jonsson R; Johannessen AC
Hum Pathol; 1999 Sep; 30(9):1097-105. PubMed ID: 10492046
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma.
Bandoh N; Hayashi T; Kishibe K; Takahara M; Imada M; Nonaka S; Harabuchi Y
Cancer; 2002 Apr; 94(7):1968-80. PubMed ID: 11932899
[TBL] [Abstract][Full Text] [Related]
20. Chemoresistance to concanamycin A1 in human oral squamous cell carcinoma is attenuated by an HDAC inhibitor partly via suppression of Bcl-2 expression.
Kiyoshima T; Yoshida H; Wada H; Nagata K; Fujiwara H; Kihara M; Hasegawa K; Someya H; Sakai H
PLoS One; 2013; 8(11):e80998. PubMed ID: 24278362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
